US Stock MarketDetailed Quotes

FORTRESS BIOTECH INC 9.375% CUM RED PER PREF SER A USD25.00 (FBIOP)

Watchlist
  • 13.120
  • -0.090-0.68%
Close Apr 16 16:00 ET
  • 13.000
  • -0.120-0.91%
Post 16:11 ET
44.96MMarket Cap0.00P/E (TTM)

FORTRESS BIOTECH INC 9.375% CUM RED PER PREF SER A USD25.00 (FBIOP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.97%-65.78M
2.81%-12.54M
69.54%-6.11M
-26.20%-27.56M
22.94%-19.56M
37.46%-80.19M
63.05%-12.91M
-19.51%-20.06M
34.40%-21.84M
41.26%-25.39M
Net income from continuing operations
72.76%-32.92M
79.49%-5.4M
133.07%8.83M
59.57%-11.65M
36.73%-24.69M
21.60%-120.86M
9.21%-26.32M
-148.92%-26.69M
51.40%-28.82M
29.24%-39.02M
Operating gains losses
-999.06%-26.73M
-18.28%398K
-119.73%-397K
-13,774.09%-26.78M
-92.95%47K
187.80%2.97M
-92.11%487K
139.18%2.01M
-102.89%-193K
109.99%667K
Depreciation and amortization
4.41%4.66M
2.84%1.16M
20.90%1.16M
-2.94%1.16M
0.00%1.19M
-25.56%4.46M
404.88%1.13M
-65.23%957K
-29.98%1.19M
-37.74%1.19M
Other non cash items
-81.25%849K
-152.24%-315K
-68.12%637K
-79.14%141K
-69.12%386K
-58.13%4.53M
-78.07%603K
2,366.67%2M
-70.52%676K
-78.02%1.25M
Change In working capital
-208.80%-25.1M
-88.47%-10.81M
18.71%-4.53M
-172.98%-6.78M
-152.60%-2.98M
35.08%-8.13M
68.41%-5.73M
32.56%-5.58M
-132.03%-2.48M
-7.83%5.67M
-Change in receivables
-532.30%-19.33M
-1,670.00%-11.78M
-141.72%-2M
461.38%2.57M
-254.51%-8.13M
-64.29%4.47M
110.45%750K
-109.25%-827K
-106.60%-712K
16,537.50%5.26M
-Change in inventory
213.78%4.81M
183.01%2.19M
149.21%1.03M
-139.87%-356K
617.38%1.94M
-206.88%-4.23M
-423.11%-2.64M
-283.98%-2.1M
-19.69%893K
-142.45%-374K
-Change in prepaid assets
347.76%1.55M
43.61%-2.55M
-15.59%1.74M
-100.62%-21K
251.24%2.38M
26.42%-624K
-11.37%-4.53M
112.11%2.07M
226.44%3.41M
-231.03%-1.57M
-Change in payables and accrued expense
-35.65%-8.55M
150.49%2.03M
43.25%-2.81M
-72.54%-8.34M
-78.64%570K
74.03%-6.3M
111.06%810K
71.52%-4.95M
-11.36%-4.83M
-44.11%2.67M
-Change in other current assets
-65.91%330K
-27.59%21K
41.67%17K
-95.60%27K
-15.34%265K
219.80%968K
-90.30%29K
101.19%12K
583.46%614K
943.33%313K
-Change in other current liabilities
-61.59%-3.9M
-374.34%-721K
-1,246.36%-2.52M
64.27%-662K
100.16%1K
21.48%-2.42M
78.29%-152K
116.88%220K
-237.52%-1.85M
-20.19%-631K
Cash from discontinued investing activities
Operating cash flow
17.97%-65.78M
2.81%-12.54M
69.54%-6.11M
-26.20%-27.56M
22.94%-19.56M
37.46%-80.19M
63.05%-12.91M
-19.55%-20.06M
34.40%-21.84M
41.26%-25.39M
Investing cash flow
Cash flow from continuing investing activities
167.47%10.12M
0
2.87M
6.09M
1.17M
-613.27%-15M
-21,958.82%-15M
0
0
0
Net PPE purchase and sale
--1.17M
--0
--0
--0
--1.17M
--0
--0
--0
--0
--0
Net intangibles purchase and sale
--0
----
----
----
----
-86.68%-15M
-42,757.14%-15M
--0
----
----
Net business purchase and sale
--8.96M
--0
--2.87M
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
167.47%10.12M
--0
--2.87M
--6.09M
--1.17M
-613.27%-15M
-23,709.52%-15M
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
9.63%77.44M
-77.88%5.71M
455.96%15.07M
-68.31%4.52M
87.16%52.14M
115.77%70.64M
-40.84%25.81M
200.97%2.71M
146.95%14.27M
25.56%27.86M
Net issuance payments of debt
23.11%-5.64M
--0
95.94%-704K
----
----
81.11%-7.33M
-65.79%5M
-73.30%-17.33M
111.50%5M
--0
Net common stock issuance
-1.40%81.68M
-74.22%5.46M
-31.77%14.14M
-17.56%9.12M
77.27%52.97M
3.07%82.84M
-31.89%21.19M
99.27%20.72M
-27.23%11.06M
26.20%29.88M
Net preferred stock issuance
---265K
--0
--0
---115K
---150K
--0
--0
--0
--0
--0
Cash dividends paid
85.90%-664K
0.00%-166K
5.68%-166K
92.40%-166K
92.40%-166K
46.28%-4.71M
92.41%-166K
91.97%-176K
0.41%-2.18M
0.46%-2.18M
Proceeds from stock option exercised by employees
171.48%2.95M
0.98%412K
1,354.84%1.8M
57.91%619K
-28.83%116K
59.62%1.09M
-18.89%408K
37.78%124K
345.45%392K
--163K
Net other financing activities
50.00%-625K
--0
--0
--0
---625K
-3.31%-1.25M
-2,504.17%-625K
----
----
----
Cash from discontinued financing activities
Financing cash flow
9.63%77.44M
-77.88%5.71M
455.96%15.07M
-68.31%4.52M
87.16%52.14M
115.77%70.64M
-40.84%25.81M
200.97%2.71M
146.95%14.27M
25.56%27.86M
Net cash flow
Beginning cash position
-29.45%58.82M
43.54%87.44M
-3.40%75.61M
7.83%92.56M
-29.45%58.82M
-53.93%83.37M
-18.50%60.92M
-12.27%78.26M
-44.59%85.84M
-53.93%83.37M
Current changes in cash
188.74%21.79M
-225.42%-6.84M
168.20%11.83M
-123.86%-16.95M
1,265.05%33.74M
74.84%-24.55M
-124.37%-2.1M
-19.93%-17.35M
88.48%-7.57M
109.50%2.47M
End cash Position
37.04%80.6M
37.04%80.6M
43.54%87.44M
-3.40%75.61M
7.83%92.56M
-29.45%58.82M
-29.45%58.82M
-18.50%60.92M
-12.27%78.26M
-44.59%85.84M
Free cash flow
30.90%-65.78M
55.05%-12.54M
69.54%-6.11M
-26.20%-27.56M
22.94%-19.56M
30.17%-95.19M
20.26%-27.91M
11.94%-20.06M
38.18%-21.84M
41.26%-25.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.97%-65.78M2.81%-12.54M69.54%-6.11M-26.20%-27.56M22.94%-19.56M37.46%-80.19M63.05%-12.91M-19.51%-20.06M34.40%-21.84M41.26%-25.39M
Net income from continuing operations 72.76%-32.92M79.49%-5.4M133.07%8.83M59.57%-11.65M36.73%-24.69M21.60%-120.86M9.21%-26.32M-148.92%-26.69M51.40%-28.82M29.24%-39.02M
Operating gains losses -999.06%-26.73M-18.28%398K-119.73%-397K-13,774.09%-26.78M-92.95%47K187.80%2.97M-92.11%487K139.18%2.01M-102.89%-193K109.99%667K
Depreciation and amortization 4.41%4.66M2.84%1.16M20.90%1.16M-2.94%1.16M0.00%1.19M-25.56%4.46M404.88%1.13M-65.23%957K-29.98%1.19M-37.74%1.19M
Other non cash items -81.25%849K-152.24%-315K-68.12%637K-79.14%141K-69.12%386K-58.13%4.53M-78.07%603K2,366.67%2M-70.52%676K-78.02%1.25M
Change In working capital -208.80%-25.1M-88.47%-10.81M18.71%-4.53M-172.98%-6.78M-152.60%-2.98M35.08%-8.13M68.41%-5.73M32.56%-5.58M-132.03%-2.48M-7.83%5.67M
-Change in receivables -532.30%-19.33M-1,670.00%-11.78M-141.72%-2M461.38%2.57M-254.51%-8.13M-64.29%4.47M110.45%750K-109.25%-827K-106.60%-712K16,537.50%5.26M
-Change in inventory 213.78%4.81M183.01%2.19M149.21%1.03M-139.87%-356K617.38%1.94M-206.88%-4.23M-423.11%-2.64M-283.98%-2.1M-19.69%893K-142.45%-374K
-Change in prepaid assets 347.76%1.55M43.61%-2.55M-15.59%1.74M-100.62%-21K251.24%2.38M26.42%-624K-11.37%-4.53M112.11%2.07M226.44%3.41M-231.03%-1.57M
-Change in payables and accrued expense -35.65%-8.55M150.49%2.03M43.25%-2.81M-72.54%-8.34M-78.64%570K74.03%-6.3M111.06%810K71.52%-4.95M-11.36%-4.83M-44.11%2.67M
-Change in other current assets -65.91%330K-27.59%21K41.67%17K-95.60%27K-15.34%265K219.80%968K-90.30%29K101.19%12K583.46%614K943.33%313K
-Change in other current liabilities -61.59%-3.9M-374.34%-721K-1,246.36%-2.52M64.27%-662K100.16%1K21.48%-2.42M78.29%-152K116.88%220K-237.52%-1.85M-20.19%-631K
Cash from discontinued investing activities
Operating cash flow 17.97%-65.78M2.81%-12.54M69.54%-6.11M-26.20%-27.56M22.94%-19.56M37.46%-80.19M63.05%-12.91M-19.55%-20.06M34.40%-21.84M41.26%-25.39M
Investing cash flow
Cash flow from continuing investing activities 167.47%10.12M02.87M6.09M1.17M-613.27%-15M-21,958.82%-15M000
Net PPE purchase and sale --1.17M--0--0--0--1.17M--0--0--0--0--0
Net intangibles purchase and sale --0-----------------86.68%-15M-42,757.14%-15M--0--------
Net business purchase and sale --8.96M--0--2.87M----------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 167.47%10.12M--0--2.87M--6.09M--1.17M-613.27%-15M-23,709.52%-15M--0--0--0
Financing cash flow
Cash flow from continuing financing activities 9.63%77.44M-77.88%5.71M455.96%15.07M-68.31%4.52M87.16%52.14M115.77%70.64M-40.84%25.81M200.97%2.71M146.95%14.27M25.56%27.86M
Net issuance payments of debt 23.11%-5.64M--095.94%-704K--------81.11%-7.33M-65.79%5M-73.30%-17.33M111.50%5M--0
Net common stock issuance -1.40%81.68M-74.22%5.46M-31.77%14.14M-17.56%9.12M77.27%52.97M3.07%82.84M-31.89%21.19M99.27%20.72M-27.23%11.06M26.20%29.88M
Net preferred stock issuance ---265K--0--0---115K---150K--0--0--0--0--0
Cash dividends paid 85.90%-664K0.00%-166K5.68%-166K92.40%-166K92.40%-166K46.28%-4.71M92.41%-166K91.97%-176K0.41%-2.18M0.46%-2.18M
Proceeds from stock option exercised by employees 171.48%2.95M0.98%412K1,354.84%1.8M57.91%619K-28.83%116K59.62%1.09M-18.89%408K37.78%124K345.45%392K--163K
Net other financing activities 50.00%-625K--0--0--0---625K-3.31%-1.25M-2,504.17%-625K------------
Cash from discontinued financing activities
Financing cash flow 9.63%77.44M-77.88%5.71M455.96%15.07M-68.31%4.52M87.16%52.14M115.77%70.64M-40.84%25.81M200.97%2.71M146.95%14.27M25.56%27.86M
Net cash flow
Beginning cash position -29.45%58.82M43.54%87.44M-3.40%75.61M7.83%92.56M-29.45%58.82M-53.93%83.37M-18.50%60.92M-12.27%78.26M-44.59%85.84M-53.93%83.37M
Current changes in cash 188.74%21.79M-225.42%-6.84M168.20%11.83M-123.86%-16.95M1,265.05%33.74M74.84%-24.55M-124.37%-2.1M-19.93%-17.35M88.48%-7.57M109.50%2.47M
End cash Position 37.04%80.6M37.04%80.6M43.54%87.44M-3.40%75.61M7.83%92.56M-29.45%58.82M-29.45%58.82M-18.50%60.92M-12.27%78.26M-44.59%85.84M
Free cash flow 30.90%-65.78M55.05%-12.54M69.54%-6.11M-26.20%-27.56M22.94%-19.56M30.17%-95.19M20.26%-27.91M11.94%-20.06M38.18%-21.84M41.26%-25.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More